$Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)$
QR Code

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

Farhad Salehzadeh,1 Yusef Mohammadikebar,2 Afsaneh Enteshary,2 Omid Ghanbarpour,1 Mehrdad Mirzarahimi11Department of Pediatric, Bouali Children’s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran; 2Department of Internal Medicine, Emam Khomeini Hospital, Ardabil Unive...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Salehzadeh F, Mohammadikebar Y, Enteshary A, Ghanbarpour O, Mirzarahimi M
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2019
Sujets:	Pyoderma Gangrenousm Infliximab Childhood Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/a574c8fa76a34d15adc1e8f58986ff1e
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:a574c8fa76a34d15adc1e8f58986ff1e
record_format	dspace
spelling	oai:doaj.org-article:a574c8fa76a34d15adc1e8f58986ff1e2021-12-02T05:40:01ZInfliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)1177-5491https://doaj.org/article/a574c8fa76a34d15adc1e8f58986ff1e2019-05-01T00:00:00Zhttps://www.dovepress.com/infliximab-in-treatment-of-idiopathic-refractory-childhood-pyoderma-ga-peer-reviewed-article-BTThttps://doaj.org/toc/1177-5491Farhad Salehzadeh,1 Yusef Mohammadikebar,2 Afsaneh Enteshary,2 Omid Ghanbarpour,1 Mehrdad Mirzarahimi11Department of Pediatric, Bouali Children’s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran; 2Department of Internal Medicine, Emam Khomeini Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, IranAbstract: We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much information available about infliximab use for biologic and childhood pyoderma gangrenosum, eventually we decided to use infliximab in this patient. Infliximab showed a dramatic response and resulted in full recovery during 2 years’ follow-up.Keywords: pyoderma gangrenosum, infliximab, childhoodSalehzadeh FMohammadikebar YEnteshary AGhanbarpour OMirzarahimi MDove Medical PressarticlePyoderma GangrenousmInfliximabChildhoodMedicine (General)R5-920ENBiologics: Targets & Therapy, Vol Volume 13, Pp 97-99 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Pyoderma Gangrenousm Infliximab Childhood Medicine (General) R5-920
spellingShingle	Pyoderma Gangrenousm Infliximab Childhood Medicine (General) R5-920 Salehzadeh F Mohammadikebar Y Enteshary A Ghanbarpour O Mirzarahimi M Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
description	Farhad Salehzadeh,1 Yusef Mohammadikebar,2 Afsaneh Enteshary,2 Omid Ghanbarpour,1 Mehrdad Mirzarahimi11Department of Pediatric, Bouali Children’s Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, Iran; 2Department of Internal Medicine, Emam Khomeini Hospital, Ardabil University of Medical Sciences (ARUMS), Ardabil, IranAbstract: We report a case of refractory idiopathic childhood pyoderma gangrenosum in a young boy who had suffered from this disease since 3 years of age. He had unfavorable responses and intermittent relapses under different combinations of cytotoxic and steroid therapies. Although there was not much information available about infliximab use for biologic and childhood pyoderma gangrenosum, eventually we decided to use infliximab in this patient. Infliximab showed a dramatic response and resulted in full recovery during 2 years’ follow-up.Keywords: pyoderma gangrenosum, infliximab, childhood
format	article
author	Salehzadeh F Mohammadikebar Y Enteshary A Ghanbarpour O Mirzarahimi M
author_facet	Salehzadeh F Mohammadikebar Y Enteshary A Ghanbarpour O Mirzarahimi M
author_sort	Salehzadeh F
title	Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
title_short	Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
title_full	Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
title_fullStr	Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
title_full_unstemmed	Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)
title_sort	infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (pg)
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/a574c8fa76a34d15adc1e8f58986ff1e
work_keys_str_mv	AT salehzadehf infliximabintreatmentofidiopathicrefractorychildhoodpyodermagangrenosumpg AT mohammadikebary infliximabintreatmentofidiopathicrefractorychildhoodpyodermagangrenosumpg AT entesharya infliximabintreatmentofidiopathicrefractorychildhoodpyodermagangrenosumpg AT ghanbarpouro infliximabintreatmentofidiopathicrefractorychildhoodpyodermagangrenosumpg AT mirzarahimim infliximabintreatmentofidiopathicrefractorychildhoodpyodermagangrenosumpg
_version_	1718400313608634368

Infliximab in treatment of idiopathic refractory childhood pyoderma gangrenosum (PG)

Documents similaires